Open access
Sep 2026
808. Low-Dose Novel FLT3 Inhibitor Demonstrates Non-Opioid Analgesic Efficacy in Thermal and Inflammatory Pain Models
Abstract Background Pain remains a significant clinical challenge, especially in chronic and treatment-resistant cases. Current pharmacological options often have limited efficacy and significant side effects, including dependence associated with opioids. FLT3 inhibitors, primarily developed for acute myeloid leukemia,...
Y. Moriya, R. Saito-Moriya, Y. Nago-Iwashita et al.
· International Journal of Neu... · 0 citations